It surrounds IP rights to certain drugs.
Planned changes to EU laws around pharmaceuticals could have a big impact here.
That's the warning from an Irish MEP, as politicians in Europe are looking at issues surround IP rights to certain drugs which current legislation protects for 8 years.
The European Commission has proposed a reduction to six years, arguing that it may lead to cheaper drugs.
Fianna Fail MEP Billy Kelleher says some major pharma companies here could be hugely affected by any changes: